{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:34:32Z","timestamp":1768970072556,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T00:00:00Z","timestamp":1277769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10072-010-0358-6","type":"journal-article","created":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T12:15:19Z","timestamp":1277727319000},"page":"833-836","source":"Crossref","is-referenced-by-count":2,"title":["Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association"],"prefix":"10.1007","volume":"31","author":[{"given":"G.","family":"Bigliardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mandrioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Valzania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Casula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"358_CR1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1191\/1352458503ms964oa","volume":"9","author":"CM Isbister","year":"2003","unstructured":"Isbister CM, Mackenzie PJ, Anderson D, Wade NK, Oger J (2003) Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 9:550\u2013553","journal-title":"Mult Scler"},{"key":"358_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2003.028233","volume":"75","author":"J Dionisiotis","year":"2004","unstructured":"Dionisiotis J, Zoukos Y, Thomaides T (2004) Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment. J Neurol Neurosurg Psychiatry 75:1079","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s004150070118","volume":"247","author":"A Frese","year":"2000","unstructured":"Frese A, Bethke F, L\u00fcdemann P, St\u00f6gbauer F (2000) Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate. J Neurol 247:713","journal-title":"J Neurol"},{"key":"358_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S0004-282X2008000200023","volume":"66","author":"PJ Lorenzoni","year":"2008","unstructured":"Lorenzoni PJ, Scola RH, Kay CS, Werneck LC (2008) Myasthenia gravis and multiple sclerosis: an uncommon presentation. Arq Neuropsiquiatr 66:251\u2013253","journal-title":"Arq Neuropsiquiatr"},{"key":"358_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-510X(89)90005-1","volume":"89","author":"H Somer","year":"1989","unstructured":"Somer H, M\u00fcller K, Kinnunen E (1989) Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings. J Neurol Sci 89:37\u201348","journal-title":"J Neurol Sci"},{"key":"358_CR6","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.49.6.1747-a","volume":"49","author":"G Blake","year":"1997","unstructured":"Blake G, Murphy S (1997) Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment. Neurology 49:1747\u20131748","journal-title":"Neurology"},{"key":"358_CR7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","volume":"68","author":"BG Weinshenker","year":"2007","unstructured":"Weinshenker BG, Jacob A (2007) Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68:1326","journal-title":"Neurology"},{"key":"358_CR8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","volume":"68","author":"I Kister","year":"2007","unstructured":"Kister I, Herbert J, Swerdlow ML, Bergamaschi R, Piccolo G, Oger J (2007) Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68:1326\u20131327","journal-title":"Neurology"},{"key":"358_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.410320319","volume":"32","author":"JW Lindsey","year":"1992","unstructured":"Lindsey JW, Albers GW, Steinman L (1992) Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Ann Neurol 32:407\u2013409","journal-title":"Ann Neurol"},{"key":"358_CR10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","volume":"6","author":"DH Miller","year":"2007","unstructured":"Miller DH, Leary SM (2007) Primary progressive multiple sclerosis. Lancet Neurol 6:903\u2013912","journal-title":"Lancet Neurol"},{"key":"358_CR11","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C, Br\u00fcck W, Rauschka H, Bergmann M et al (2005) Cortical demyelination and diffusewhite matter injury inmultiple sclerosis. Brain 128:2705\u20132712","journal-title":"Brain"},{"key":"358_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jocn.2003.12.013","volume":"11","author":"MP Pender","year":"2004","unstructured":"Pender MP (2004) The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair? J Clin Neurosci 11:689\u2013692","journal-title":"J Clin Neurosci"},{"key":"358_CR13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:691\u2013693","journal-title":"Ann Neurol"},{"key":"358_CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","volume":"18","author":"A Vincent","year":"2005","unstructured":"Vincent A, Leite MI (2005) Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 18:519\u2013525","journal-title":"Curr Opin Neurol"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis. Brain 131:1940\u20131952","journal-title":"Brain"},{"key":"358_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.10441","volume":"53","author":"LM Villar","year":"2003","unstructured":"Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, Roldan E, Bootello A, Alvarez-Cermeno JC (2003) Intrathecal IgM synthesis is a prognostic factor in MS. Ann Neurol 53:222\u2013226","journal-title":"Ann Neurol"},{"key":"358_CR17","first-page":"824","volume":"58","author":"LM Villar","year":"2002","unstructured":"Villar LM, Masjuan J, Gonz\u00e1lez-Porqu\u00e9 P, Plaza J, S\u00e1daba MC, Rold\u00e1n E, Bootello A, \u00c1lvarez-Cerme\u00f1o JC (2002) Intrathecal IgM synthesis in neurological diseases. Relationship with disability in MS. Neurology 58:824\u2013826","journal-title":"Relationship with disability in MS. Neurology"},{"key":"358_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI22833","volume":"115","author":"LM Villar","year":"2005","unstructured":"Villar LM, S\u00e1daba MC, Rold\u00e1n E, Gonz\u00e1lez-Porqu\u00e9 P, Plaza J, Bootello A, \u00c1lvarez-Cerme\u00f1o JC (2005) Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J Clin Invest 115:187\u2013194","journal-title":"J Clin Invest"},{"key":"358_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1352458507082046","volume":"14","author":"LM Villar","year":"2008","unstructured":"Villar LM, Garc\u00eda-Barrag\u00e1n N, Espi\u00f1o M, Rold\u00e1n E, S\u00e1daba MC, G\u00f3mez-Rial J, Gonz\u00e1lez-Porqu\u00e9 P, \u00c1lvarez-Cerme\u00f1o JC (2008) Influence of oligoclonal IgM specificity in multiple sclerosis disease course. Mult Scler 14:183\u2013187","journal-title":"Mult Scler"},{"key":"358_CR20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/1352458508095729","volume":"14","author":"M Thangarajh","year":"2008","unstructured":"Thangarajh M, Gomez-Rial J, Hedstr\u00f6m AK, Hillert J, Alvarez-Cerme\u00f1o JC, Masterman T, Villar LM (2008) Lipid-specific immunoglobulin M in CSF predicts adverse. Mult Scler 14:1208\u20131213","journal-title":"Mult Scler"},{"key":"358_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2009.03.003","volume":"211","author":"LM Villar","year":"2009","unstructured":"Villar LM, Masterman T, Casanova B, G\u00f3mez-Rial J, Espi\u00f1o M, S\u00e1daba MC, Gonz\u00e1lez-Porqu\u00e9 P, Coret F, \u00c1lvarez-Cerme\u00f1o JC (2009) CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis. J Neuroimmunol 211:101\u2013104","journal-title":"J Neuroimmunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-010-0358-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-010-0358-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-010-0358-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:45Z","timestamp":1559121105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-010-0358-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s10072-010-0358-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}